CVE-2026-83143 in Siebel Apps
Summary
by MITRE • 09/16/2026
Vulnerability in the Siebel Apps - Life Sciences product of Oracle Siebel CRM (component: eDetailing). Supported versions that are affected are 17.0-26.7. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Siebel Apps - Life Sciences. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Siebel Apps - Life Sciences accessible data as well as unauthorized access to critical data or complete access to all Siebel Apps - Life Sciences accessible data. CVSS 3.1 Base Score 8.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:N).
Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.
Analysis
by VulDB Data Team • 09/16/2026
The identified vulnerability resides within the eDetailing component of Oracle Siebel Apps for Life Sciences, specifically affecting versions ranging from 17.0 through 26.7. This security flaw represents a significant risk to organizations utilizing this customer relationship management platform within the pharmaceutical and healthcare sectors. The core technical issue involves an authentication bypass mechanism that permits unauthenticated actors to interact with critical application functions over HTTP. While the vulnerability is classified as easily exploitable due to its low attack complexity, it does require human interaction from a victim other than the attacker to trigger the malicious payload. This characteristic aligns with common web-based exploitation techniques where social engineering or phishing tactics are employed to lure users into executing actions that inadvertently invoke the vulnerable code paths within the eDetailing module.
From an operational perspective, the impact of this vulnerability is severe, as indicated by a CVSS 3.1 Base Score of 8.1. The primary consequences involve high-impact breaches in both confidentiality and integrity. An attacker who successfully exploits this flaw can gain unauthorized access to critical data or achieve complete access to all Siebel Apps for Life Sciences accessible data. Furthermore, the vulnerability allows for the unauthorized creation, deletion, or modification of such data. This capability undermines the fundamental security principles of availability, integrity, and confidentiality, potentially leading to significant regulatory non-compliance, especially given that life sciences companies are subject to strict data protection regulations regarding patient information and proprietary research data. The ability to modify critical records poses a direct threat to business continuity and operational accuracy within pharmaceutical sales and marketing operations.
In terms of industry standard classifications, this vulnerability exhibits characteristics consistent with CWE-287 Improper Authentication, as it allows unauthenticated access to protected resources. Additionally, the requirement for human interaction suggests an attack vector often associated with CWE-79 Cross-site Scripting or similar injection flaws that rely on user engagement, although the specific mechanism is not detailed in the advisory. From a tactical standpoint, this aligns with MITRE ATT&CK techniques related to Initial Access via Phishing if social engineering is used, and subsequent actions would fall under Data Exfiltration over C2 channels or Data Manipulation depending on whether the attacker reads or alters data. The network-based nature of the exploit means it can be leveraged remotely without prior access credentials, increasing its potential for widespread exploitation across internet-facing deployments.
Mitigation strategies must prioritize immediate patching to the latest supported version of Oracle Siebel Apps for Life Sciences that addresses this specific eDetailing flaw. Organizations should also implement strict network segmentation and web application firewalls configured to detect anomalous HTTP requests targeting the affected components. Since human interaction is a prerequisite, security awareness training focused on identifying suspicious links or actions within the CRM interface is essential. Additionally, enforcing HTTPS exclusively for all Siebel applications can help mitigate certain types of interception attacks that might facilitate this vulnerability in transit environments. Regular audits of access controls and monitoring for unusual data modification patterns will aid in early detection of any attempted exploitation activities.